GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Health Guard Biotechnology Inc (BJSE:833575) » Definitions » Cash per Share

Beijing Health Guard Biotechnology (BJSE:833575) Cash per Share : ¥0.49 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Health Guard Biotechnology Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Beijing Health Guard Biotechnology's Cash per Share for the quarter that ended in Mar. 2024 was ¥0.49.


Beijing Health Guard Biotechnology Cash per Share Historical Data

The historical data trend for Beijing Health Guard Biotechnology's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Health Guard Biotechnology Cash per Share Chart

Beijing Health Guard Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 3.48 5.38 2.37 0.50

Beijing Health Guard Biotechnology Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.55 1.26 0.90 0.50 0.49

Beijing Health Guard Biotechnology Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Beijing Health Guard Biotechnology's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Beijing Health Guard Biotechnology's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Health Guard Biotechnology  (BJSE:833575) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Beijing Health Guard Biotechnology Cash per Share Related Terms

Thank you for viewing the detailed overview of Beijing Health Guard Biotechnology's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Health Guard Biotechnology (BJSE:833575) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Room 201 and 202, Building A2, Beijing, CHN, 100176
Website
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.

Beijing Health Guard Biotechnology (BJSE:833575) Headlines

No Headlines